Rakhi Kumar - Dec 20, 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Chief Accounting Officer
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar
Stock symbol: ROIV
Transactions as of: Dec 20, 2023
Transactions value $: -$13,585
Form type: 4
Date filed: 12/22/2023, 07:00 PM
Previous filing: Nov 27, 2023
Next filing: Dec 29, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ROIV	Common Shares	Tax liability	-$13.6K	-1.36K	-0.7%	$9.96	192K	Dec 20, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.